Zoledronic acid: A new parenteral bisphosphonate

Author： Li E.C.   Davis L.E.  

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.11, 2003-11, pp. : 2669-2708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New Adjuvants for Parenteral and Mucosal Vaccines: Nouveaux adjuvants en vaccination systémique ou muqueuse

By Guy Bruno   Burdin Nicolas  

Therapie, Vol. 60, Iss. 3, 2005-01 ,pp. : 235-241

Adis International

Access to resources Recommend Favorite

Clinical and experimental pharmacology of parenteral spiramycin

By  

Journal of the American Association for Laboratory Animal Science, Vol. 3, Iss. 3, 1962-05 ,pp. : 305-313

American Association for Laboratory Animal Science

Access to resources Recommend Favorite

Home parenteral nutrition: An ethical decision making dilemma

By Breier-Mackie Sarah   Newell Christopher J.  

The Australian Journal of Advanced Nursing, Vol. 19, Iss. 4, 2002-08 ,pp. : 27-32

Australian Nursing Federation

Access to resources Recommend Favorite

Non-Animal Stabilized Hyaluronic Acid: A New Formulation for the Treatment of Osteoarthritis

By ågerup Bengt  

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 23-30

Adis International

Access to resources Recommend Favorite

Bisphosphonate Effects in Cancer and Inflammatory Diseases: In Vitro and In Vivo Modulation of Cytokine Activities

By Daniele Santini   Maria E. Fratto   Bruno Vincenzi   Annalisa La Cesa   Caterina Dianzani   Giuseppe Tonini  

BioDrugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 269-278

Adis International

Access to resources Recommend Favorite